| Volume: | 36,106,256 |
|---|---|
| Day's Low: | $16.82 |
| 52-wk Low: | $11.62 |
| Previous Close: | $17.02 |
| Dividend: | $0.16 |
| Market Cap: | 114,465,500 |
| Avg Volume: | 54,506,400 |
|---|---|
| Day's High: | $17.02 |
| 52-wk High: | $18.48 |
| Open Price: | $17.01 |
| Yield: | 3.77% |
| P/E (Forward): | 8.40 |
| 3:17 PM | 11/6/2009 | UPDATE: Abbott Labs: US Justice Department Probing Depakote |
| 9:04 AM | 11/6/2009 | Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor |
| 12:38 PM | 11/5/2009 | Merckle To Narrow Bid List For Ratiopharm In Next Few Weeks |
| 7:17 AM | 11/5/2009 | Pfizer Vaccine Batch Recalled In Netherlands After Deaths |
| 7:17 AM | 11/5/2009 | CORRECT (11/6): Pfizer Vaccine Batch Quarantined In Netherlands After Deaths |
| 4:04 AM | 11/5/2009 | Alliance Pharma 9-Months Sales +44%; To Beat Fiscal Year Expectations |
| 3:37 AM | 11/3/2009 | GlaxoSmithKline, Pfizer Launches Specialist HIV Company |
| 11/5/2009 | Cramer on BloggingStocks: All I'm asking for is rigor |
| 11/4/2009 | Still Waiting for Details on Merck's 16,000 Job Cuts |
| 11/4/2009 | Merck: We're Number Two |
| 11/4/2009 | Merck, Pfizer, J&J lead drug stocks higher |
| 11/4/2009 | Which Blue Chips Had Q3 Revenue Growth? |
| 11/3/2009 | November Starts Strong for M&A |
| 11/3/2009 | Recapping 40,000 Job Cuts in Big Pharma |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.51 | 0.62 | -17.74 |
| EPS, GAAP | 0.43 | 0.34 | 26.47 |
| Consensus Estimate | 0.48 | 0.60 | -20.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.18 | 2.42 | -9.92 |
| EPS, GAAP | 1.12 | 1.55 | -27.74 |
| Consensus Estimate | 2.02 | NA | NA |
| PFE | Industry Average | |
| P/E (TTM) | 15.14 | 18.40 |
| P/E (Forward) | 8.40 | -4.30 |
| PEG Ratio | -11.20 | -0.28 |
| Price/Sales | 2.48 | 2.94 |
| Beta | 0.71 | 0.74 |